Skip to main content

allergy is required, and form is required

New ASCIA antibiotic allergy challenge resources - April 2022

ASCIA is intending to apply for a Medicare Benefits Schedule (MBS) item number for antibiotic allergy challenges in 2022. In preparation for this application, a new ASCIA FAQ for patients and carers, as well as a new Consent Form, have been developed,...

Economic Impact of Allergies

The cost of allergies to the Australian economy is more than $7 billion per year, and most Australians face a wait many months to see a specialist, if they can access care at all. These are among key findings in a report by Access Economics to be...

Anaphylaxis Checklists

ASCIA has developed the following five checklists to assist in the management of patients who are at risk of severe allergic reactions (anaphylaxis). Anaphylaxis Checklist - Prescribers (Doctors and Nurse Practitioners) Anaphylaxis Checklist -...

Allergen Immunotherapy (AIT)

Frequently Asked Questions This document has been developed by ASCIA, the peak professional body of clinical immunology/allergy specialists in Australia and New Zealand. ASCIA information is based on published literature and expert review, is not...

Adrenaline (Epinephrine) Injectors for General Use

Adrenaline (epinephrine) injectors (e.g. EpiPen® or Anapen®) are approved for use in Australia and New Zealand for the emergency treatment of anaphylaxis, the most severe form of allergic reaction. ASCIA cannot dictate policy regarding the use of...

Nutricia allergy formula supply issues - February 2022

Nutricia has advised that they are continuing to experience supply issues with Allerpro Syneo Stages 1 and 2, Pepti Junior and Neocate Junior Unflavoured (see table below). Nutricia has also advised that there is good supply for Neocate Gold and...

Venom Immunotherapy (VIT)

Frequently Asked Questions This document has been developed by ASCIA, the peak professional body of clinical immunology/allergy specialists in Australia and New Zealand. ASCIA information is based on published literature and expert review, is not...

Venom Allergy

Health Professional Information Allergen and Venom Immunotherapy Aeroallergen and Venom Immunotherapy FAQ - Availability and Regulation in Australia ASCIA Allergen Immunotherapy e-training for health professionals ASCIA Guide - Venom Immunotherapy,...

ASCIA Clinical History Form

This form includes type in fields and tick boxes that can be completed by the patient (or their parent/carer) and provided to the patient’s doctor or nurse practitioner before, or at the time of their appointment. The completed form can be saved and...

Adrenaline Injectors

This webpage includes links to: Supply updates | PBS listings | FDA report about EpiPen® | Process to follow during shortages | Adrenaline Injector dose guide Supply updates January 2024 Adrenaline (Epinephrine) Injector Training Devices ASCIA...

Access to skin prick testing reagents

Skin prick testing is the primary mode of testing for immediate IgE-mediated allergy for clinical immunology/allergy specialists and other doctors or nurse practitioners who have been trained to manage patients with allergic disease. Skin prick testing...

Mastocytosis and Other Mast Cell Disorders

Frequently Asked Questions This document has been developed by ASCIA, the peak professional body of clinical immunology/allergy specialists in Australia and New Zealand. ASCIA information is based on published literature and expert review, is not...

AIFA 2024 Research Grant Round Open - EOIs due 14 May 2024

The Allergy and Immunology Foundation of Australia (AIFA) 2024 grant round is now open and Expressions of Interest (EOIs) are invited from ASCIA members for AIFA research grants. EOIs are due by midnight on 14 May 2024 and the application form is on...

Subcutaneous Immunoglobulin (SCIg) Therapy

Frequently Asked Questions April 2024 Update This document has been developed by ASCIA, the peak professional body of clinical immunology/allergy specialists in Australia and New Zealand. ASCIA information is based on published literature and expert...

Other Allergy

Health Professional Information ASCIA Guidelines - Management of Latex-Allergic Individuals Allergic Reactions Clinical History Form (with type in fields and tick boxes) Allergic Reactions Event Record (with type in fields and tick boxes) Further...

Dietary Guide - Two Food Elimination Diet (2FED) for EoE

This document has been developed by ASCIA, the peak professional body of clinical immunology/allergy specialists in Australia and New Zealand. ASCIA information is based on published literature and expert review, is not influenced by commercial...

Vasculitis Disorders

Frequently Asked Questions This document has been developed by ASCIA, the peak professional body of clinical immunology/allergy specialists in Australia and New Zealand. ASCIA information is based on published literature and expert review, is not...

ASCIA Food Allergen Challenges Consent Form

This consent form should be completed and signed by the patient, or their parent/guardian prior to the patient commencing a food allergen challenge. ASCIA Food Allergen Challenges Consent Form99.35 KB ©ASCIA 2022 ASCIA is the peak professional body of...